Literature DB >> 9580611

Spectroscopic studies of nitric oxide (NO) interactions with cobalamins: reaction of NO with superoxocobalamin(III) likely accounts for cobalamin reversal of the biological effects of NO.

H Kruszyna1, J S Magyar, L G Rochelle, M A Russell, R P Smith, D E Wilcox.   

Abstract

Recent reports indicate that oxidized cobalamin, Cbl(III), can interfere with the biological effects of nitric oxide (NO) on vascular and visceral smooth muscle and in other systems. In attempting to elucidate the mechanism of these effects of Cbl(III), we reported that a Cbl(III)NO complex could be detected by electron paramagnetic resonance (EPR) spectroscopy, but not by ultraviolet/visible spectroscopy. Subsequently, others concluded that the alleged Cbl(III)NO complex is detectable by ultraviolet/visible, but not by EPR spectroscopy and provided ultraviolet/visible evidence for an alleged Cbl(III)NO complex. We report further investigation of the interaction of NO with Cbl, using both techniques, Fourier transform infrared (FTIR) spectroscopy and mass spectrometry. Our EPR results and the UV/VIS results of others appear to be experimental artifacts that can now, at least in part, be explained. Under conditions where FTIR measurements readily detect a N-O stretching frequency of NO bound to Fe(II), we do not detect a similar signal that can be ascribed to either Cbl(III)NO or Cbl(II)NO, indicating that neither Cbl(III) nor Cbl(II) form a stable complex with NO. Loss of the Cbl(II) EPR signal and mass spectral detection of N2O upon addition of NO to Cbl(II) solutions, demonstrates that Cbl(II), which is present in aerobic Cbl(III) solutions, reduces NO; however, this reaction does not appear to be fast enough to account for the observed biological effects in aerated media. Nitric oxide also reacts rapidly and irreversibly with the superoxo complex of Cbl(III), Cbl(III)O2-, which is always present in aerated solutions of Cbl(III). We believe that this latter reaction accounts for the observed inactivation of NO by Cbl(III) in biological systems. Because Cbl(III)O2- is spontaneously regenerated from Cbl(II) and O2 in aerated solutions, this may constitute a cyclic mechanism for the rapid elimination (oxidation) of NO. Thus, several physicochemical techniques fail to provide convincing evidence for the existence of stable Cbl(III)NO or Cbl(II)NO complexes but do provide evidence that Cbl species participate in redox reactions with NO under aerobic conditions, thereby inhibiting its physiological roles.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9580611

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Comparison of the redox forms of nitrogen monoxide with the nitrergic transmitter in the rat anococcygeus muscle.

Authors:  C G Li; J Karagiannis; M J Rand
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

2.  Inhibition of nitric oxide synthase by cobalamins and cobinamides.

Authors:  J Brice Weinberg; Youwei Chen; Ning Jiang; Bethany E Beasley; John C Salerno; Dipak K Ghosh
Journal:  Free Radic Biol Med       Date:  2009-03-27       Impact factor: 7.376

3.  Comment on the importance of using nitric oxide gas in the synthesis of nitrosylcobalamin and ICH-validated methods to assess purity and stability.

Authors:  Annette M Sysel; Michael J Dunphy; Daniel J Lindner; Joseph A DiDonato; Joseph A Lupica; Joseph Alan Bauer
Journal:  J Biol Chem       Date:  2020-10-23       Impact factor: 5.157

4.  Effects of agents that inactivate free radical NO (NO*) on nitroxyl anion-mediated relaxations, and on the detection of NO* released from the nitroxyl anion donor Angeli's salt.

Authors:  A Ellis; H Lu; C G Li; M J Rand
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

5.  Effects of interferon beta on transcobalamin II-receptor expression and antitumor activity of nitrosylcobalamin.

Authors:  Joseph A Bauer; Bei H Morrison; Ronald W Grane; Barbara S Jacobs; Sally Dabney; Ana M Gamero; Kevin A Carnevale; Daniel J Smith; Judith Drazba; Bellur Seetharam; Daniel J Lindner
Journal:  J Natl Cancer Inst       Date:  2002-07-03       Impact factor: 13.506

6.  The Unexpected Role of Calcium-Activated Potassium Channels: Limitation of NO-Induced Arterial Relaxation.

Authors:  Johannes Schmid; Bettina Müller; David Heppeler; Dina Gaynullina; Mario Kassmann; Hristo Gagov; Mitko Mladenov; Maik Gollasch; Rudolf Schubert
Journal:  J Am Heart Assoc       Date:  2018-03-24       Impact factor: 5.501

7.  The ent-15α-Acetoxykaur-16-en-19-oic Acid Relaxes Rat Artery Mesenteric Superior via Endothelium-Dependent and Endothelium-Independent Mechanisms.

Authors:  Eurica Adélia Nogueira Ribeiro; Edla de Azevedo Herculano; Cintia Danieli Ferreira da Costa; Fabiola Fialho Furtado; Emídio Vasconcelos Leitão da-Cunha; José Maria Barbosa-Filho; Marcelo Sobral da Silva; Isac Almeida de Medeiros
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-27       Impact factor: 2.629

8.  Biphasic modulation of NOS expression, protein and nitrite products by hydroxocobalamin underlies its protective effect in endotoxemic shock: downstream regulation of COX-2, IL-1β, TNF-α, IL-6, and HMGB1 expression.

Authors:  André L F Sampaio; Jesmond Dalli; Vincenzo Brancaleone; Fulvio D'Acquisto; Mauro Perretti; Carmen Wheatley
Journal:  Mediators Inflamm       Date:  2013-05-28       Impact factor: 4.711

9.  The return of the Scarlet Pimpernel: cobalamin in inflammation II - cobalamins can both selectively promote all three nitric oxide synthases (NOS), particularly iNOS and eNOS, and, as needed, selectively inhibit iNOS and nNOS.

Authors:  Carmen Wheatley
Journal:  J Nutr Environ Med       Date:  2007-09

10.  N-Salicyloyltryptamine, an N-Benzoyltryptamine Analogue, Induces Vasorelaxation through Activation of the NO/sGC Pathway and Reduction of Calcium Influx.

Authors:  Robson Cavalcante Veras; Darizy Flávia Silva; Lorena Soares Bezerra; Valéria Lopes de Assis; Walma Pereira de Vasconcelos; Maria do Carmo Alustau; José George Ferreira de Albuquerque; Fabíola Fialho Furtado; Islania Giselia de Albuquerque Araújo; Fátima de Lourdes Assunção Araújo de Azevedo; Thais Porto Ribeiro; José Maria Barbosa-Filho; Stanley Juan Chavez Gutierrez; Isac Almeida Medeiros
Journal:  Molecules       Date:  2018-01-28       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.